One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Contents
doi : 10.1016/S0161-6420(23)00441-4
Volume 130, Issue 9, September 2023, Pages A7, A8, A10, A12, A14
This Issue at a Glance
Sandeep Ravindran, PhD
doi : 10.1016/j.ophtha.2023.07.005
Volume 130, Issue 9, September 2023, Page 879
A Simple Vista en Este Número
Sandeep Ravindran, PhD
doi : 10.1016/j.ophtha.2023.07.010
Volume 130, Issue 9, September 2023, Pages e1-e2
期刊一览
Sandeep Ravindran, PhD
doi : 10.1016/j.ophtha.2023.07.016
Volume 130, Issue 9, September 2023, Page e3
The Issue of End Point Discordance in Dry Age-Related Macular Degeneration: How Might Clinical Trials Demonstrate a Functional Benefit?
Eleonora M. Lad, MD, PhD - Durham, North Carolina Usha Chakravarthy, FRCOphth, PhD
doi : 10.1016/j.ophtha.2023.05.020
Volume 130, Issue 9, September 2023, Pages 890-892
Association of Systemic Medication Use with Glaucoma and Intraocular Pressure: The European Eye Epidemiology Consortium
Joëlle E. Vergroesen, MSc,1,2, * Alexander K. Schuster, MD,3, * Kelsey V. Stuart, MBBCh, MSc,4 Nigus G. Asefa, PhD,5 Audrey Cougnard-Grégoire, PhD,6 Cécile Delcourt, PhD,6 Cédric Schweitzer, MD, PhD,6,7 Patr?cia Barreto, PharmD, MSc,8,9 Rita Coimbra, PhD,8,10 Paul J. Foster, PhD, FRCS(Ed),4 Robert N. Luben, PhD,4,11 Norbert Pfeiffer, MD,3 Julia V. Stingl, MD,3 Toralf Kirsten, PhD, 12,13,14 Franziska G. Rauscher, PhD,12,13 Kerstin Wirkner, PhD,12,13 Nomdo M. Jansonius, MD, PhD,5 Louis Arnould, MD, PhD,15 Catherine P. Creuzot-Garcher, MD, PhD,15 Bruno H. Stricker, MD, PhD,2 Christina Keskini, MD,16 Fotis Topouzis, MD, PhD,16 Geir Bertelsen, MD, PhD,17 Anne E. Eggen, PhD, 17 Mukharram M. Bikbov, MD,18 Jost B. Jonas, MD,18,19,20 Caroline C.W. Klaver, MD, PhD,1,2,19,21 Wishal D. Ramdas, MD, PhD,1,y Anthony P. Khawaja, MD, PhD,4,11,y on behalf of the European Eye Epidemiology Consortium
doi : 10.1016/j.ophtha.2023.05.001
Volume 130, Issue 9, September 2023, Pages 893-906
Causes of Childhood Blindness in the United States Using the IRIS® Registry (Intelligent Research in Sight)
Han Woong Lim, MD, PhD, 1,2 Suzann Pershing, MD,1,3 Darius M. Moshfeghi, MD,1 Hwan Heo, MD, PhD,1,4 Md Enamul Haque, PhD,1 Scott R. Lambert, MD,1 on behalf of the IRIS? Registry Analytic Center Consortium
doi : 10.1016/j.ophtha.2023.04.004
Volume 130, Issue 9, September 2023, Pages 907-913
Goldenhar Syndrome Patient with Craniocerebral Lesion
MINGYU R EN , MM ED RUIMIAO L I, MM ED LIMIN L IU , MM ED
doi : 10.1016/j.ophtha.2022.09.019
Volume 130, Issue 9, September 2023, Page 913
Intravitreal Therapy for Uveitic Macular Edema—Ranibizumab versus Methotrexate versus the Dexamethasone Implant: The MERIT Trial Results
The Multicenter Uveitis Steroid Treatment Trial (MUST) Research Group, Writing Committee: Nisha R. Acharya, MD, MS,1,2,3 Albert T. Vitale, MD,4 Elizabeth A. Sugar, PhD, 5,6 Janet T. Holbrook, PhD,5 Alyce E. Burke, MPH, 5 Jennifer E. Thorne, MD, PhD,5,7 Michael M. Altaweel, MD,8 John H. Kempen, MD, PhD, 9,10,11,12 Douglas A. Jabs, MD, MBA
doi : 10.1016/j.ophtha.2023.04.011
Volume 130, Issue 9, September 2023, Pages 914-923
Immediate Sequential Bilateral Surgery in Refractive Lens Exchange Patients: Clinical Outcomes and Adverse Events
Stephen J. Hannan, OD, 1 Steven C. Schallhorn, MD,1,2,3 Jan A. Venter, MD,1 David Teenan, MD,1 Julie M. Schallhorn, MD2,4
doi : 10.1016/j.ophtha.2023.04.013
Volume 130, Issue 9, September 2023, Pages 924-936
One-Year Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large United States Cohort in the IRIS® Registry
Mathew W. MacCumber, MD, PhD,1 Charles C. Wykoff, MD, PhD, 2 Helene Karcher, PhD,3 Eser Adiguzel, PhD,4 Samriddhi Buxy Sinha, PhD,5 Saloni Vishwakarma, MS, 6 Andrew LaPrise, BS,6 Franklin Igwe, MPharm,3 Rita Freitas, PharmD, MSc, 7 Michael S. Ip, MD,8 Marco A. Zarbin, MD, PhD
doi : 10.1016/j.ophtha.2023.04.012
Volume 130, Issue 9, September 2023, Pages 937-946
Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents, and Age-Related Macular Degeneration Study: A Randomized Controlled Trial for Submacular Hemorrhage Secondary to Age-Related Macular Degeneration
Pierre-Henry Gabrielle, MD, PhD,1 Marie-Noëlle Delyfer, MD, PhD, 2 Agnès Glacet-Bernard, MD,3 Jean Baptiste Conart, MD, PhD,4 Joel Uzzan, MD,5 Laurent Kodjikian, MD, PhD,6,7 Carl Arndt, MD, PhD,8 Ramin Tadayoni, MD, PhD,9 Agnès Soudry-Faure, PharmD, PhD, 10 Catherine P. Creuzot Garcher, MD, PhD
doi : 10.1016/j.ophtha.2023.04.014
Volume 130, Issue 9, September 2023, Pages 947-957
Malignant Idiopathic Intracranial Hypertension
ANNE STRONG CALDWELL , MD 1 NIHAAL M EHTA , MD 1 PREM S. S UBRAMANIAN, MD, P H D
doi : 10.1016/j.ophtha.2022.09.006
Volume 130, Issue 9, September 2023, Page 957
Side Effects of Proton Beam Radiotherapy Treatment on Iris Melanoma
Katharina Eibenberger, MD,1 Heinrich Heimann, MD, PhD,1,2 Leandro Gatchalian, MD,1 Andrzej Kacperek, PhD,3 Rumana Hussain, MBBS, MD
doi : 10.1016/j.ophtha.2023.05.004
Volume 130, Issue 9, September 2023, Pages 958-965
The Biosimilar Paradox: How Anti–Vascular Endothelial Growth Factor Biosimilars Could Increase Patient and Overall Health Care Costs
Casey Zhang, AB, 1 Scott Friedman, MD,2 Prithvi Mruthyunjaya, MD, MHS, 3 Ravi Parikh, MD, MPH
doi : 10.1016/j.ophtha.2023.04.019
Volume 130, Issue 9, September 2023, Pages 966-972
Peripheral Anterior Synechiae as a Manifestation of Axenfeld-Rieger Anomaly
ARNAV PANIGRAHI , MBBS SHIKHA GUPTA , MD VINEY G UPTA , MD
doi : 10.1016/j.ophtha.2022.09.008
Volume 130, Issue 9, September 2023, Page 972
Ophthalmologist Turnover in the United States: Analysis of Workforce Changes from 2014 through 2021
Prem N. Patel, BSA,1 Parth A. Patel, BS, 2 Amar H. Sheth, BSA,3 Harris Ahmed, DO, MPH,4 Tedi Begaj, MD,5 Ravi Parikh, MD, MPH
doi : 10.1016/j.ophtha.2023.05.003
Volume 130, Issue 9, September 2023, Pages 973-981
A Blinding Glioma
ALEXANDRE DENTEL , MD 1 ARNAULT TAUZIEDE -E SPARIAT , MD 2 ALEJANDRA DARUICH , MD, P HD 1
doi : 10.1016/j.ophtha.2022.09.010
Volume 130, Issue 9, September 2023, Page 982
Trends in Ophthalmology Practice Consolidation: 2015–2022
Jacob F. Smith, BS,1 Braden C. Hintze, 2 Scott T. Anderson, BS, 3 Prashant D. Tailor, MD,4 Timothy T. Xu, MD,4 Matthew R. Starr, MD
doi : 10.1016/j.ophtha.2023.05.006
Volume 130, Issue 9, September 2023, Pages 983-992
An Iris Heterochromia Typical of Rubella
VINEY G UPTA , MD 1 ABHISHEK SINGH , BSC 1 SHIKHA GUPTA , MD
doi : 10.1016/j.ophtha.2022.09.016
Volume 130, Issue 9, September 2023, Page 992
Predictors of Poor Visual Outcome in Myelin Oligodendrocyte Glycoprotein-Related Optic Neuritis
ARMIN HANDZIC , MD 1,* MARKO T IEN, BS C 2,* ROISIN M AIRE O’CEARBHAILL, MD 3 JIM S HENCHU X IE , BHS C 4 KIRILL ZASLAVSKY, MD, P H D1 JONATHAN M ICIELI , MD 1,5,6 EDWARD M ARGOLIN , MD
doi : 10.1016/j.ophtha.2023.05.024
Volume 130, Issue 9, September 2023, Pages 993-995
Follow-up Extension Up to 43Â Years of Modified Osteo-Odonto-Keratoprosthesis
PAOLO COLLIARDO, MD 1 ANDREA T ALONI , MD 2 MAURIZIO T ALONI , MD 1 GIOVANNI F ALCINELLI , MD 3 LUIGI PETITTI , MD 2 ANDREA L UCISANO , MD 2 MASSIMO B USIN , MD 4,5,6 VINCENZO SCORCIA , MD 2 GIUSEPPE G IANNACCARE, MD, P H D
doi : 10.1016/j.ophtha.2023.05.010
Volume 130, Issue 9, September 2023, Pages 995-997
Re: Banks et al.: Ophthalmologic involvement in adults with histiocytic disorders: clinical presentation and treatment outcomes (Ophthalmology. 2023;130:77-86)
J ASMINE H. F RANCIS , MD, FACS DAVID H. A BRAMSON , MD, FACS ELI L. DIAMOND, MD
doi : 10.1016/j.ophtha.2023.03.029
Volume 130, Issue 9, September 2023, Page e33
Reply
SAMANTHA A. B ANKS , MD 1 M. T ARIQ BHATTI , MD 1,2 R ONALD S. G O , MD 3 J ITHMA P. ABEYKOON , MD 3 A LDO A. ACOSTA-M EDINA , MD 4 A NTONIOUS Z. H AZIM , MD 4 G AURAV G OYAL , MD 5 J ASON R. Y OUNG , MD 6 M ATTHEW J. KOSTER , MD 7 R OBERT V ASSALLO , MD 8 J AY H. RYU , MD 8 C AROLINE J. D AVIDGE -P ITTS , MBBC H 9 A ISHWARYA R AVINDRAN , MBBS 10 J ULIO C. S ARTORI VALINOTTI , MD 11 N. NORA BENNANI, MD 3 M ITHUN V. S HAH , MD, P H D3 K AREN L. RECH , MD 10 J AMES A. GARRITY , MD 2 W. O LIVER T OBIN , MBBC H, P H D
doi : 10.1016/j.ophtha.2023.05.017
Volume 130, Issue 9, September 2023, Pages e33-e34
